Product Description
Overall, the global peripheral intravenous catheter market was valued at $1.7 billion in 2023. This is expected to increase over the forecast period at a CAGR of 2.2% to reach $1.9 billion.
Throughout this medical market research, we analyzed over 20 peripheral intravenous catheter companies across 7 continents and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts. The full report suite on the global market for peripheral intravenous catheters includes conventional peripheral intravenous catheters and safety intravenous catheters.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2030, and Historical Data to 2020
- Market Drivers & Limiters for Each Segment
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- COVID19 Impact
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
Global Peripheral Intravenous Catheter Market Insights

On a worldwide scale, it is projected that peripheral intravenous catheter procedures will experience a modest increase over the forecast period. This growth is mainly due to population changes. The global population is growing at about 1% each year, and the elderly population is increasing even faster. This is foreseen to lead to an increase in hospitalizations, consequently driving up the demand for vascular access devices, notably peripheral intravenous catheters.
Global Peripheral Intravenous Catheter Market Insights

- In 2023, Becton Dickinson (BD) led the peripheral intravenous catheter market, emphasizing safety and blood control devices. BD excels in both segments, particularly dominating the non-blood control safety sector with products like Insyte® Autoguard® catheters. In the blood control category, they sell Nexiva™ devices and Insyte® Autoguard® BC.
- B. Braun competes in the safety peripheral intravenous catheter market with Introcan Safety® IV catheters and Introcan Safety® 3 closed IV catheters. These devices resemble traditional ones but are popular for their automatic safety features. Lower-priced peripheral intravenous catheters also contributed to increased market share. Additionally, B. Braun‘s Ster-ASSIST™ peripheral IV catheter insertion kit aligns with the trend of ultrasound-guided insertion.
- ICU Medical ranked third, offering both conventional and safety peripheral intravenous catheters. In the safety sector, their Jelco® ProtectIV® competes with BD’s Insyte® Autoguard®. The acquisition of Smiths Medical strengthened their position. They also offer OPTIVA®, made from Ocrilon® polyurethane, which reduces the risk of phlebitis.
Market Segmentation Summary
- Conventional Peripheral Intravenous Catheter Market
- Safety Peripheral Intravenous Catheter Market
Global Research Scope Summary
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2023 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.